Related Experiment Video
Updated: May 16, 2026
05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
A Monte Carlo tool to study the mortality reduction due to breast screening programs.
Luis I Zamora1, Cristina Forastero, Damian Guirado
1Hospital Universitario Reina Sofía, Córdoba, Spain.
Medical Physics
|December 13, 2012
Summary
This study developed a Monte Carlo tool to assess breast cancer screening program effectiveness. Results show significant mortality reductions, highlighting screening acceptance as a critical factor.
Area of Science:
- Oncology
- Public Health
- Medical Imaging
Background:
- Breast cancer remains a significant global health concern, necessitating effective screening strategies.
- Early detection through screening programs is crucial for reducing mortality rates.
- Assessing the impact of screening program parameters is vital for optimizing public health interventions.
Purpose of the Study:
- To develop a Monte Carlo simulation tool for evaluating breast cancer mortality reduction from screening programs.
- To quantify the impact of various screening parameters on mortality rates.
- To provide insights for optimizing breast cancer screening program design and implementation.
Main Methods:
- Utilized Monte Carlo simulations to model individual woman histories within screening programs.
- Incorporated survival models for invasive cancers and time-gain distributions for screening vs. symptomatic detection.
- Calculated mortality rates for the entire population and age-specific cohorts.
Main Results:
- A reduction in breast cancer mortality of up to 29% was observed with a 100% acceptance rate in women aged 50-70, screened biennially.
- Reduced acceptance rates (70%) decreased mortality reduction to 20%.
- Earlier screening initiation (age 40) or shorter intervals (1 year) showed substantial mortality reductions (24% and 28%, respectively).
Conclusions:
- The simulation tool's results align with existing trial data, validating its predictive capabilities.
- Acceptance rates above 50% are crucial for achieving meaningful mortality reductions (12%-20%).
- Screening program acceptance rate is a critical parameter influencing overall effectiveness.
Related Concept Videos
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:20Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
01:19The Mantel-Cox Log-Rank Test
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of interest.
01:18Introduction To Survival Analysis
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
The primary goal of survival analysis is to estimate survival time—the time until a...